World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
39
Citations
4531
World Ranking
8407
National Ranking
296

Shingo Nishiyama publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Shingo Nishiyama sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 124 publications — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Shingo Nishiyama D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Shingo Nishiyama sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 39 D-Index — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Shingo Nishiyama is affiliated with Hamamatsu Photonics in Japan and has contributed to research primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work extends into various subfields including Molecular Biology, Physiology, Psychiatry and Mental Health, Oncology, and Pediatrics, Perinatology and Child Health.

Their research topics cover a range of areas with notable focus on Mitochondrial Function and Pathology, Drug Transport and Resistance Mechanisms, Pharmacological Effects and Toxicity Studies, Alzheimer's Disease Research and Treatments, Epilepsy Research and Treatment, Neuroinflammation and Neurodegeneration Mechanisms, and Neuroscience and Neuropharmacology Research.

Recent papers authored or co-authored by Nishiyama include:

  • 18F-Labeled dihydromethidine: positron emission tomography radiotracer for imaging of reactive oxygen species in intact brain, 2020, Organic & Biomolecular Chemistry
  • Head-to-head comparison of (R)-[11C]verapamil and [18F]MC225 in non-human primates, tracers for measuring P-glycoprotein function, 2021, European Journal of Nuclear Medicine and Molecular Imaging
  • Evaluation of intracellular processes in quinolinic acid-induced brain damage by imaging reactive oxygen species generation and mitochondrial complex I activity, 2021, EJNMMI Research
  • Pharmacokinetic Modeling of (R)-[11C]verapamil to Measure the P-Glycoprotein Function in Nonhuman Primates, 2020, Molecular Pharmaceutics
  • Brain p3-Alcβ peptide restores neuronal viability impaired by Alzheimer's amyloid β-peptide, 2023, EMBO Molecular Medicine

Frequent co-authors collaborating with Nishiyama include:

  • Hideo Tsukada
  • Hiroyuki Ohba
  • Masakatsu Kanazawa
  • Takeharu Kakiuchi
  • Yasushi Arano

Their work has been published across several venues with multiple contributions, notable publication outlets include:

  • Research Square
  • Organic & Biomolecular Chemistry
  • European Journal of Nuclear Medicine and Molecular Imaging
  • EJNMMI Research
  • Molecular Pharmaceutics

Best Publications

  • Ketamine decreased striatal [11C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: Multiparametric PET studies combined with microdialysis analysis

    Hideo Tsukada;Norihiro Harada;Shingo Nishiyama;Hiroyuki Ohba

  • Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain

    Hideo Tsukada;Shingo Nishiyama;Takeharu Kakiuchi;Hiroyuki Ohba

  • Real Time Visualization of 13N-Translocation in Rice under Different Environmental Conditions Using Positron Emitting Tracer Imaging System

    Shoichiro Kiyomiya;Hiromi Nakanishi;Hiroshi Uchida;Atsunori Tsuji

  • Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys.

    Kenji Hashimoto;Takeharu Kakiuchi;Hiroyuki Ohba;Shingo Nishiyama

  • Is synaptic dopamine concentration the exclusive factor which alters the in vivo binding of [11C]raclopride?: PET studies combined with microdialysis in conscious monkeys

    Hideo Tsukada;Shingo Nishiyama;Takeharu Kakiuchi;Hiroyuki Ohba

  • Comparative effects of methamphetamine and nicotine on the striatal [11C]raclopride binding in unanesthetized monkeys

    Hideo Tsukada;Katsumasa Miyasato;Takeharu Kakiuchi;Shingo Nishiyama

  • Docosahexaenoic acid (DHA) improves the age-related impairment of the coupling mechanism between neuronal activation and functional cerebral blood flow response: a PET study in conscious monkeys.

    Hideo Tsukada;Takeharu Kakiuchi;Dai Fukumoto;Shingo Nishiyama

  • Effects of binge pattern cocaine administration on dopamine D1 and D2 receptors in the rat brain: an in vivo study using positron emission tomography.

    Hideo Tsukada;Jason Kreuter;Christopher E. Maggos;Ellen M. Unterwald;Ellen M. Unterwald

  • Chronic NMDA antagonism impairs working memory, decreases extracellular dopamine, and increases D1 receptor binding in prefrontal cortex of conscious monkeys.

    Hideo Tsukada;Shingo Nishiyama;Dai Fukumoto;Kengo Sato

  • Cholinergic Neuronal Modulation Alters Dopamine D2Receptor Availability In Vivo by Regulating Receptor Affinity Induced by Facilitated Synaptic Dopamine Turnover: Positron Emission Tomography Studies with Microdialysis in the Conscious Monkey Brain

    Hideo Tsukada;Norihiro Harada;Shingo Nishiyama;Hiroyuki Ohba

  • Decline of striatal dopamine release in parkin‐deficient mice shown by ex vivo autoradiography

    Shigeto Sato;Shigeto Sato;Tomoki Chiba;Shingo Nishiyama;Takeharu Kakiuchi

  • Ketamine alters the availability of striatal dopamine transporter as measured by [(11)C]beta-CFT and [(11)C]beta-CIT-FE in the monkey brain.

    Hideo Tsukada;Shingo Nishiyama;Takeharu Kakiuchi;Hiroyuki Ohba

  • Subanesthetic Doses of Ketamine Transiently Decrease Serotonin Transporter Activity: A PET Study in Conscious Monkeys

    Shigeyuki Yamamoto;Hiroyuki Ohba;Shingo Nishiyama;Norihiro Harada

  • Effects of acute acetylcholinesterase inhibition on the cerebral cholinergic neuronal system and cognitive function: Functional imaging of the conscious monkey brain using animal PET in combination with microdialysis.

    Hideo Tsukada;Shingo Nishiyama;Dai Fukumoto;Hiroyuki Ohba

  • Development of novel PET probes, [18F]BCPP-EF, [18F]BCPP-BF, and [11C]BCPP-EM for mitochondrial complex 1 imaging in the living brain.

    Norihiro Harada;Shingo Nishiyama;Masakatsu Kanazawa;Hideo Tsukada

  • Evaluation of d-Isomers of O-11C-Methyl Tyrosine and O-18F-Fluoromethyl Tyrosine as Tumor-Imaging Agents in Tumor-Bearing Mice: Comparison with l- and d-11C-Methionine

    Hideo Tsukada;Kengo Sato;Dai Fukumoto;Shingo Nishiyama

  • [11C]CHIBA-1001 as a Novel PET Ligand for α7 Nicotinic Receptors in the Brain: A PET Study in Conscious Monkeys

    Kenji Hashimoto;Shingo Nishiyama;Hiroyuki Ohba;Masaaki Matsuo

  • Age-related impairment of coupling mechanism between neuronal activation and functional cerebral blood flow response was restored by cholinesterase inhibition: PET study with microdialysis in the awake monkey brain.

    Hideo Tsukada;Kengo Sato;Takeharu Kakiuchi;Shingo Nishiyama

  • An increase of sigma1 receptors in the aged monkey brain

    Kazunori Kawamura;Yuichi Kimura;Hideo Tsukada;Tadayuki Kobayashi

  • Protective effects of N-acetyl-L-cysteine on the reduction of dopamine transporters in the striatum of monkeys treated with methamphetamine.

    Kenji Hashimoto;Hideo Tsukada;Shingo Nishiyama;Dai Fukumoto

Frequent Co-Authors

Hideo Tsukada
Hideo Tsukada Hamamatsu Photonics (Japan)
Takeharu Kakiuchi
Takeharu Kakiuchi Hamamatsu Photonics (Japan)
Kenji Hashimoto
Kenji Hashimoto Chiba University
Masaomi Iyo
Masaomi Iyo Chiba University
Yasuomi Ouchi
Yasuomi Ouchi Hamamatsu University
Ronald Boellaard
Ronald Boellaard Amsterdam UMC
Edward F. Domino
Edward F. Domino University of Michigan–Ann Arbor
Hiromi Nakanishi
Hiromi Nakanishi University of Tokyo
Kohji Sato
Kohji Sato Hamamatsu University
Mary Jeanne Kreek
Mary Jeanne Kreek Rockefeller University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Shingo Nishiyama

Trending Scientists

Recently Published Articles